COVID-19 UPDATES • 9/2/2020
Bioinformatics and genomics experts from the Jacobs School of Medicine and Biomedical Sciences will contribute to a $4 million interdisciplinary study of bacteria in the mouth and periodontal disease in postmenopausal women.
A new way to generate oligodendrocytes has potential to enhance treatments for brain injury, MS, Alzheimer’s and more.
“I’ve met some amazing people at UB…I mean this with my heart and soul."
- Raj Suchak, Founder
“Through the collaboration with UB, I got the first IRB approval for acquiring human tissues for our experiment.”
- Dr. Vladik Sandler, CEO/CSO